Avicenna Days 2026 is a special anniversary edition celebrating 10 years of the Avicenna Alliance and its mission to advance the adoption of in silico methods across healthcare. This two-day online event will bring together the global in silico community to look back at key milestones, share lessons learned, and define priorities for the next decade of digital evidence, computational modelling and simulation in research, regulation, and clinical practice..
AVICENNA DAYS (AAD) 2026
Free, Online, In Silico HealthcareEvent
Tuesday 28 – Wednesday 29 April 2026, 2-6 pm CET Looking Back: A Decade of In Silico Progress
Over the past ten years, the Avicenna Alliance has played a central role in:
Advancing the scientific foundations of in silico medicine
Supporting dialogue between academia, industry, regulators, clinicians, and patients
Promoting the use of digital evidence in regulatory and clinical decision-making
Building a strong, interdisciplinary international community
AAD 2026 will highlight key achievements, landmark initiatives, and turning pointsthat have shaped the field since the Alliance’s creation.
Looking Forward: The Next 10 Years
While progress has been significant, important challenges and opportunities remain. AAD 2026 will focus on:
Scaling adoption of in silico methods across healthcare sectors
Strengthening regulatory confidence and harmonisation
Improving model credibility, transparency, and usability
Ensuring patient-centred, inclusive, and impactful innovation
Participants will contribute to a forward-looking discussion on how in silicomedicine can deliver safer, faster, and more effective healthcare in the decade ahead.
Who should attend?
Academic and industry researchers and leaders in medical devices, bio/pharma, and digital health
Scientists and regulatory affairs professionals working with digital evidence
Clinicians and healthcare professionals interested in practical in silico applications
Policy makers, notified bodies, patient representatives, and innovation stakeholders
What you will gain
By attending AAD 2026, you will:
Gain a comprehensive overview of 10 years of progress in in silico medicine.
Hear strategic perspectives from academic, industry, and regulatory leaders.
Engage directly with experts and peers to discuss future priorities and next steps at the intersection of innovation and patient safety.
Join us
Celebrate the 10th anniversary of the Avicenna Alliance and be part of the conversation shaping the future of in silico healthcare.
Avicenna Days (AAD) 2026 10 Years of the Avicenna Alliance Programme
28 April 2026 «Reflecting on a Decade of Progress — Shaping the Future of In SilicoMedicine» - The Avicenna Policy Development WG and Research & Technology WG
14:00 - 14:05 Welcome Roberta Maggi, Office Manager, Avicenna Alliance 14:05 - 14:20 Happy Anniversary Avicenna Alliance Thierry Marchal, President & Secretary General, Avicenna Alliance, Ansys part of Synopsys 14:20 - 14:40 Keynote: "Evolving from conservative industry norms to a smarter EU-driven future” - ABSTRACT Bassil Akra, Chief Executive Officer, Akra Team 14:40 - 16:10 The Policy Development Working Group Martha De Cunha, Policy Development WG Leader, Master of Ceremony, Avicenna Alliance, Edwards Lifesciences Mark Grumbridge, Head of Clinical Investigations, MHRA Sara Bridio, Scientific Project Officer, European Commission Surash Surash, Clinical Reviewer, Tuv Sud Round Table Moderator Martha De Cunha, Policy Development WG Leader, Master of Ceremony, Avicenna Alliance, Edwards Lifesciences Panelists: - Mark Grumbridge, Head of Clinical Investigations, MHRA - Sara Bridio, Scientific Project Officer, European Commission - Surash Surash, Clinical Reviewer, Tuv Sud Wrap Up Martha De Cunha, Policy Development WG Leader, Master of Ceremony, Avicenna Alliance, Edwards Lifesciences
16:10 - 16:20 BREAK
16:20 - 17:50 The Research & Technology Working Group Liesbet Geris, Research & Technology WG Leader, Master of Ceremony, Avicenna Alliance, VPH Society Maria Angeles Pérez Ansón, Professor Mechanical Engineering Department, University of Zaragoza Nirnith Devireddy, Co-Chair of the Artificial Intelligence (AI) Task Force, Founder and CEO, InSilicoMinds Vincenzo Carbone, Head of R&I, InSilicoTrials Nele Famaey, Soft Tissue Biomechanics Professor, KU Leuven - "C4Bio: Where Do We Go from Here?" - ABSTRACT Heleen Fehervary, Research Manager in Biomechanics, FIBEr (KU Leuven Core Facility for Biomechanical Experimentation) Round Table Moderator Liesbet Geris, Research & Technology WG Leader, Master of Ceremony, Avicenna Alliance, VPH Society Panelists: - Maria Angeles Pérez Ansón, Professor Mechanical Engineering Department, University of Zaragoza - Nirnith Devireddy, Co-Chair of the Artificial Intelligence (AI) Task Force, Founder and CEO, InSilicoMinds - Vincenzo Carbone, Head of R&I, InSilicoTrials - Nele Famaey, Soft Tissue Biomechanics Professor, KU Leuven - Heleen Fehervary, Research Manager in Biomechanics, FIBEr (KU Leuven Core Facility for Biomechanical Experimentation) Wrap Up Liesbet Geris, Research & Technology WG Leader, Master of Ceremony, Avicenna Alliance, VPH Society 17: 50 - 18:00 WRAP UP Thierry Marchal, President & Secretary General, Avicenna Alliance, Ansys part of Synopsys
29 April 2026 «Reflecting on a Decade of Progress — Shaping the Future of In SilicoMedicine» - The Avicenna International Affairs WG and In Silico Application (ISA) WG
14:00 - 14:05 Welcome Roberta Maggi, Office Manager, Avicenna Alliance Thierry Marchal, President & Secretary General, Avicenna Alliance, Ansys part of Synopsys 14:05 - 14:15 "VPH 2026, the largest conference and forum for the in silicosociety" - ABSTRACT Francesco Migliavacca, Full Professor of Bioengineering, Politecnico of Milan (Polimi) 14:15 - 14:35 Keynote: “From old dreams to current reality in Virtual Human Twins: large-scale in silicotrials, drug-device modelling, and the heart-brain axis” - ABSTRACT Oscar Camara, Director of Engineering School, Universidad Pompeu Fabra (UPF) 14:35 - 16:15 The In Silico Application (ISA) Working Group Cécile Rousseau, In Silico Application (ISA) WG Leader, Master of Ceremony, Avicenna Alliance, VCLS Matthieu Chareyre, Founder, Qualified Person and President, Tox by Design Erica Beaucage-Gauvreau, iSi Health Manager, iSi Health Karl Bass, Principal Model-Based Systems Engineer, Bespak - "Computational Modelling and Simulation at Bespak R&D" - ABSTRACT Round Table - “The Village Behind In Silico Innovation: All Roads Lead to the Patient” - ABSTRACT Moderator Rene Bombien, Co-Chair of the ISA Clinical Deployment TF, Avicenna Alliance, Clinical Directo, Qtec Panelists: - Julien Clin, Co-Chair of the Nonclinical Application Task Force, Avicenna Alliance, Scientific Director, Numalogics - Brent Craven, Professor of Mechanical Engineering, Baylor University - Charlott Danielson, Research Scientist, Fraunhofer IMTE - Vijay Govindarajan, Scientist, Boston Children's Hospital and Harvard Medical School - Dr. Richard Assaker, Professor of Neurosurgery, Lille's CHRU, Co-Founder, MDsim
16:15 - 16:25 BREAK
16:25 - 17:55 The International Affairs Working Group Marc Horner, International Affairs WG Leader, Master of Ceremony, Avicenna Alliance, Ansys part of Synopsys Flora Musuamba, Vice Chair Person, Modelling and Simulation Working Party, EMA Jaesoon Choi, Full Professor, Department of Biomedical Engineering, University of Ulsan College of Medicine and Asan Medical Center David Hau, Senior Medical Adviser, TGA Andrea Manfrin, Deputy Director Clinical Investigations and Trials, MHRA Pras Pathmanathan, Senior Scientist, US Food and Drug Admnistration (FDA) Round Table - " Harmonizing the Future: Global Regulatory Perspectives on In Silico Evidence" - ABSTRACT Moderator Tina Morrison, Global Harmonization TF Leader, Avicenna Alliance, Vice President of Scientific Strategy, EQTYLab: Panelists: - Flora Musuamba, Vice Chair Person, Modelling and Simulation Working Party, EMA -Andrea Manfrin, Deputy Director Clinical Investigations and Trials, MHRA - Pras Pathmanathan, Senior scientist, US Food and Drug Administration (FDA) - Marc Horner, International Affairs WG Leader, Master of Ceremony, Avicenna Alliance, Ansys part of Synopsys
17: 55 - 16:05 WRAP UP Thierry Marchal, President & Secretary General, Avicenna Alliance, Ansys part of Synopsys
Speakers
Andrea Manfrin
Deputy Director Clinical Investigations and Trials
MHRA
READ BIO
Bassil Akra
Chief Executive Officer
Akra Team
READ BIO
Brent Craven
Professor of Mechanical Engineering, Director, Biomedical Engineering Program
Baylor University
READ BIO
Charlott Danielson
Research Scientist
Fraunhofer Research Institution for Individualized Medical Technology and Engineering (IMTE)
READ BIO
David Hau
Senior Medical Adviser
TGA
READ BIO
Erica Beaucage-Gauvreau
Co-Chair of the Clinical Deployment Task Force
Institute Manager of iSi Health, the KU
Leuven institute of Physics-based modeling for in silico …
READ BIO
Flora Musuamba
Vice Chair person, Modelling and Simulation Working Party
EMA
READ BIO
Francesco Migliavacca
Full Professor of Bioengineering
Politecnico di Milano
READ BIO
Heleen Fehervary
Research Manager in Biomechanics
FIBEr (KU Leuven Core Facility for Biomechanical Experimentation)
READ BIO
Jaesoon Choi
Full Professor in the Department of Biomedical Engineering
University of Ulsan College of Medicine and Asan Medical Center in Seoul, Korea
READ BIO
Julien Clin
Co-Chair of the Nonclinical Application Task Force
Numalogics
READ BIO
Karl Bass
Principal Model-Based Systems Engineer
Bespak
READ BIO
Maria Angeles Perez-Anson
Professor Mechanical Engineering Department
Associate Director of the Engineering Research Institute of Aragon (I3A)
University of Zaragoza
READ BIO
Mark Grumbridge
Head of Clinical Investigations
UK Medicines and Healthcare products Regulatory Agency (MHRA)
READ BIO
Matthieu Chareyre
Founder, Qualified Person and President
Tox by Design
READ BIO
Nele Famaey
Co-chair of the Tissue Characterization Task Force
Soft Tissue Biomechanics Professor, KU Leuven
READ BIO
Nirnith Devireddy
Co-Chair of the Artificial Intelligence (AI) Task Force
Founder and CEO
InSilicoMinds (Ikiminds Pvt Ltd.)
READ BIO
Oscar Camara
Director of the Engineering School
Universitat Pompeu Fabra
READ BIO
Pras Pathmanathan
Senior scientist
US Food and Drug Administration
READ BIO
Rene Bombien
Co-Chair of the Clinical Deployment Task Force
Clinical Director, Qtec
READ BIO
Richard Assaker
Professor of Neurosurgery Lille’s CHRU
Co-Founder, MDSim
READ BIO
Sara Bridio
Project Officer
Joint Research Centre (JRC) of the European Commission
READ BIO
Surash Surash
Clinical Reviewer
TÜV-SÜD
READ BIO
Tina Morrison
Co-Chair of the Global Harmonization Task Force
Vice President of Scientific Strategy
EQTYLab
READ BIO
Vijay Govindarajan
Scientist
Boston Children's Hospital
Harvard Medical School
READ BIO
Vincenzo Carbone
Head of R&I
InSilicoTrials
READ BIO
Cécile Rousseau
In Silico Application Working Group Leader
Senior Director, Nonclinical & Early Clinical Development, VCLS
